Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Predictive role of GSTs on the prognosis of breast cancer patients with neoadjuvant chemotherapy.

Bai YL, Zhou B, Jing XY, Zhang B, Huo XQ, Ma C, He JM.

Asian Pac J Cancer Prev. 2012;13(10):5019-22.

2.

Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.

Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S.

Urol Oncol. 2013 Oct;31(7):1193-203. doi: 10.1016/j.urolonc.2011.11.027. Epub 2011 Dec 11.

PMID:
22154357
3.

Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.

Ott K, Lordick F, Becker K, Ulm K, Siewert J, Höfler H, Keller G.

Int J Colorectal Dis. 2008 Aug;23(8):773-82. doi: 10.1007/s00384-008-0490-4. Epub 2008 Apr 29.

PMID:
18443805
4.
5.

Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach.

Tulsyan S, Chaturvedi P, Agarwal G, Lal P, Agrawal S, Mittal RD, Mittal B.

Mol Diagn Ther. 2013 Dec;17(6):371-9. doi: 10.1007/s40291-013-0045-4.

PMID:
23812950
6.

Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.

Zhong SL, Zhou SF, Chen X, Chan SY, Chan E, Ng KY, Duan W, Huang M.

Eur J Pharm Sci. 2006 May;28(1-2):77-85. Epub 2006 Feb 20.

PMID:
16488119
7.

Association of glutathione-S-transferase gene polymorphism and lipoprotein subclasses in hemodialysis patients.

Vekic J, Zeljkovic A, Jelic-Ivanovic Z, Damjanovic T, Suvakov S, Matic M, Savic-Radojevic A, Simic T, Spasojevic-Kalimanovska V, Gojkovic T, Spasic S, Dimkovic N.

Clin Biochem. 2014 Apr;47(6):398-403. doi: 10.1016/j.clinbiochem.2013.11.011. Epub 2013 Nov 27.

PMID:
24291050
8.

XRCC1 and ADPRT polymorphisms associated with survival in breast cancer cases treated with chemotherapy.

Ye S, Rong J, Huang SH, Zheng ZS, Yun M, Wang SM.

Asian Pac J Cancer Prev. 2012;13(10):4923-6.

9.

Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma.

Atanaskovic L, Cikota-Aleksic B, Tarabar O, Trimcev J, Zivanovic-Ivic A, Marjanovic S, Magic Z.

J BUON. 2016 Nov-Dec;21(6):1459-1465.

10.

GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer.

Oliveira AL, Rodrigues FF, Santos RE, Aoki T, Rocha MN, Longui CA, Melo MB.

Genet Mol Res. 2010 Jun 11;9(2):1045-53. doi: 10.4238/vol9-2gmr726.

11.

Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Eralp Y, Keskin S, Akışık E, Akışık E, İğci A, Müslümanoğlu M, Yılmaz S, Tunacı M, Çamlıca H, Tuzlalı S, Saip P, Dalay N, Özmen V, Topuz E.

Am J Clin Oncol. 2013 Jun;36(3):215-23. doi: 10.1097/COC.0b013e318243913f.

PMID:
22441341
12.

Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.

Saxena A, Dhillon VS, Raish M, Asim M, Rehman S, Shukla NK, Deo SV, Ara A, Husain SA.

Breast Cancer Res Treat. 2009 Jun;115(3):537-43. doi: 10.1007/s10549-008-0098-y. Epub 2008 Jun 24.

PMID:
18574688
13.

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.

Ludovini V, Antognelli C, Rulli A, Foglietta J, Pistola L, Eliana R, Floriani I, Nocentini G, Tofanetti FR, Piattoni S, Minenza E, Talesa VN, Sidoni A, Tonato M, Crinò L, Gori S.

BMC Cancer. 2017 Jul 26;17(1):502. doi: 10.1186/s12885-017-3483-2.

14.

Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.

Safarinejad MR, Shafiei N, Safarinejad SH.

Prostate Cancer Prostatic Dis. 2011 Jun;14(2):105-13. doi: 10.1038/pcan.2010.54. Epub 2011 Jan 18.

PMID:
21243008
15.

GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.

Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Tulic C, Coric V, Simic T.

Urol Oncol. 2013 Oct;31(7):1184-92. doi: 10.1016/j.urolonc.2011.08.005.

PMID:
24075358
16.
17.

Glutathione S-transferase polymorphisms influence chemotherapy response and treatment outcome in breast cancer.

Wang J, Wang T, Yin GY, Yang L, Wang ZG, Bu XB.

Genet Mol Res. 2015 Sep 22;14(3):11126-32. doi: 10.4238/2015.September.22.6.

18.

Glutathione S-transferase M1 and T1 polymorphism and response to neoadjuvant chemotherapy (CAF) in breast cancer patients.

Mishra A, Chandra R, Mehrotra PK, Bajpai P, Agrawal D.

Surg Today. 2011 Apr;41(4):471-6. doi: 10.1007/s00595-009-4310-4. Epub 2011 Mar 23.

PMID:
21431478
19.

Role of GSTM1 (Null/Present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: a case control study from South India.

Samson M, Swaminathan R, Rama R, Sridevi V, Nancy KN, Rajkumar T.

Asian Pac J Cancer Prev. 2007 Apr-Jun;8(2):253-7.

20.

Role of GSTM1 (Present/Null) and GSTP1 (Ile105Val) polymorphisms in susceptibility to acute lymphoblastic leukemia among the South Indian population.

Suneetha KJ, Nancy KN, Rajalekshmy KR, Sagar TG, Rajkumar T.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):733-6.

Supplemental Content

Support Center